down arrow

Pfizer

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,053.50
21.55 (0.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 10.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Nov'09
Nov'08
Dec'07
Nov'07
Net Sales
772.27
681.70
676.69
676.69
Other Operating Income
24.37
22.90
0.00
0.00
Total Operating income
796.64
704.60
676.69
676.69
Raw Material Cost
198.67
187.66
139.71
139.71
Purchase of Finished goods
79.12
74.96
89.58
89.58
(Increase) / Decrease In Stocks
9.91
-22.49
4.77
4.77
Employee Cost
123.88
102.09
101.70
101.70
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
226.89
210.14
205.71
205.71
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
-0.00
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
638.47
552.36
541.47
541.47
Operating Profit (PBDIT) excl Other Income
158.17
152.24
135.22
135.22
Other Income
71.05
70.11
343.07
343.07
Operating Profit (PBDIT)
229.22
222.35
478.29
478.29
Interest
0.00
0.00
0.02
0.02
Exceptional Items
-10.92
207.90
-17.35
-17.35
Gross Profit (PBDT)
218.30
430.25
460.92
460.92
Depreciation
8.29
11.12
9.58
9.58
Profit Before Tax
210.01
419.13
451.34
451.34
Tax
72.89
119.55
111.34
111.34
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
137.12
299.58
340.00
340.00
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
137.12
299.58
340.00
340.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
137.12
299.58
340.00
340.00
Equity Capital
29.84
29.84
29.84
29.84
Face Value
10.0
10.0
10.0
10.0
Reserves
964.72
871.25
619.88
619.88
Earnings per share (EPS)
45.95
100.4
113.94
113.94
Diluted Earnings per share
45.95
100.4
113.94
113.94
Operating Profit Margin (Excl OI)
19.85%
21.61%
19.98%
19.98%
Gross Profit Margin
27.4%
61.06%
68.11%
68.11%
PAT Margin
17.21%
42.52%
50.24%
50.24%
Public Share Holdings (%)
29.25%
58.77%
59.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -9.55% vs -7.13% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is -11.64% vs 1.86% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -21.46% vs -3.22% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 15.09% vs 27.65% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Pfizer With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
772.27
10,334.77
-9,562.50
-92.53%
Other Operating Income
24.37
0.00
24.37
Total Operating income
796.64
10,334.77
-9,538.13
-92.29%
Raw Material Cost
198.67
1,853.52
-1,654.85
-89.28%
Purchase of Finished goods
79.12
1,409.85
-1,330.73
-94.39%
(Increase) / Decrease In Stocks
9.91
-53.67
63.58
118.46%
Employee Cost
123.88
2,274.73
-2,150.85
-94.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
226.89
0.00
226.89
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
-0.00
2,315.28
-2,315.28
-100.00%
Total Expenditure (Excl Depreciation)
638.47
7,799.71
-7,161.24
-91.81%
Operating Profit (PBDIT) excl Other Income
158.17
2,535.06
-2,376.89
-93.76%
Other Income
71.05
280.86
-209.81
-74.70%
Operating Profit (PBDIT)
229.22
2,815.92
-2,586.70
-91.86%
Interest
0.00
33.53
-33.53
-100.00%
Exceptional Items
-10.92
0.00
-10.92
Gross Profit (PBDT)
218.30
2,782.39
-2,564.09
-92.15%
Depreciation
8.29
398.25
-389.96
-97.92%
Profit Before Tax
210.01
2,384.14
-2,174.13
-91.19%
Tax
72.89
457.58
-384.69
-84.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
137.12
1,926.56
-1,789.44
-92.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
137.12
1,926.56
-1,789.44
-92.88%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
137.12
1,912.90
-1,775.78
-92.83%
Equity Capital
29.84
40.06
-10.22
-25.51%
Face Value
10.00
1.00
0.00
Reserves
964.72
9,323.03
-8,358.31
-89.65%
Earnings per share (EPS)
45.95
47.75
-1.80
-3.77%
Diluted Earnings per share
45.95
47.68
-1.73
-3.63%
Operating Profit Margin (Excl OI)
19.85%
24.53%
0.00
-4.68%
Gross Profit Margin
27.40%
26.92%
0.00
0.48%
PAT Margin
17.21%
18.79%
0.00
-1.58%
Public Share Holdings (%)
29.25%
0.00%
29.25
29.25%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,193.17 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -9.55% vs -7.13% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit 551.33 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -11.64% vs 1.86% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 635.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -21.46% vs -3.22% in Mar 2023

Annual - Interest
Interest 15.41 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 15.09% vs 27.65% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.97%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023